Corrections
Abstract
In the article "Oral Physostigmine Treatment of Patients With Alzheimer's Disease" by Richard C. Mohs, Ph.D., et al., in the January 1985 issue, in table 1 on page 30, the replication ADAS score during placebo administration for patient 3 should have been 66.2. The percent change in replication ADAS score for patient 2 should have been 19.1; for patient 6 it should have been 4.5; and for patient 7 it should have been 3.5. The staff regrets these errors.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
